Skip to content
The Policy VaultThe Policy Vault

Benlysta — Blue Cross Blue Shield of Oklahoma

active systemic lupus erythematosus (SLE)

Initial criteria

  • If approving initial loading dose for Benlysta, approve the loading dose per FDA labeling for 1 month, followed by maintenance dosing for the remainder of the length of approval.

Approval duration

1 month loading + 11 months maintenance (total 12 months)